Activities per year
- 1,550 - 1,600 out of 2,300 results
Search results
-
Preferential Cytotoxicity of Citrus microcarpa peel against Pancreatic Cancer Cell Lines in Nutrient Deprived Conditions
Morita, H. (Speaker)
2014/03/28 → 2014/03/30Activity: Talk or presentation › Oral presentation
-
Preferential cytotoxic constituents from Aframomum melegueta against human pancreatic cancer cell line
Morita, H. (Speaker)
2014/03/28 → 2014/03/30Activity: Talk or presentation › Oral presentation
-
Prediction of genes involved in terpenoid diversity in #IScoparia dulcis#IR L.
Yamamura, Y. (Speaker)
2015/10/25 → 2015/10/30Activity: Talk or presentation › Oral presentation
-
Pre-administration of docetaxel inhibits Adriamycin-induced cardiotoxicity
To, H. (Speaker)
2011/03Activity: Talk or presentation › Oral presentation
-
Polyoxygenated cyclohexane from Kaempferia rotunda and their cytotoxic activity
Morita, H. (Speaker)
2014/03/28 → 2014/03/30Activity: Talk or presentation › Oral presentation
-
SPARCはアルツハイマー病モデルマウス脳内で軸索を正しく再伸長させ記憶障害を回復する
Yang, X. (Speaker) & Tohda, C. (Speaker)
2024/03/28 → 2024/03/31Activity: Talk or presentation › Oral presentation
-
Plastic changes in nociceptive excitatory synaptic transmission induced of bone cancer model mice, and selective antinociceptive actions of TRPA1 channel agonists and local anesthetics.
Uta, D. (Speaker)
2012/02/24 → 2012/02/25Activity: Talk or presentation › Oral presentation
-
Plastic changes in nociceptive excitatory synaptic transmission induced in bone cancer model mice, and selective antinociceptive actions of local anesthetics and TRPA1 channel agonist.
Uta, D. (Speaker)
2012/03/06 → 2012/03/07Activity: Talk or presentation › Oral presentation
-
Plants (Journal)
Awale, S. (Editor in chief)
2018 → …Activity: Publication peer-review and editorial work › Editorial work
-
Pituitary adenylate cyclase-activating polypeptide (PACAP) induces activity-dependent gene expression through the potentiation of N-methyl-D-aspartate (NMDA-R) in neurons.
Tabuchi, A. (Speaker)
2009/10Activity: Talk or presentation › Oral presentation
-
Piperine enhances the efficacy of trail-based therapy for triple-negative breast cancer cells.
Yokoyama, S. (Speaker)
2014/09Activity: Talk or presentation › Oral presentation
-
PiccoloのSNPであるrs13438494は遺伝子関連解析において依存性関連疾患と関連がありドパミンおよびセロトニンの取り込みを制御する
Nitta, A. (Speaker)
2014/03/19 → 2014/03/21Activity: Talk or presentation › Oral presentation
-
Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization.
Nitta, A. (Speaker)
2009/09/16 → 2009/09/18Activity: Talk or presentation › Oral presentation
-
Photophysical Properties of Perylenes Having Substituents at 3-Position and Their reactivities
Chiba, J. (Speaker)
2006/11/03 → 2006/11/06Activity: Talk or presentation › Oral presentation
-
Photooxygenation of Alkynylperylenes. Formation of Dibenzo[jk,mn]phenanthrene-4.5-diones
Chiba, J. (Speaker)
2007/11/22 → 2007/11/25Activity: Talk or presentation › Oral presentation
-
Photochemical Casting of a Fluorophore Concomitant with a Cleavable Photoaffinity Cross-Linking
Tomohiro, T. (Speaker)
2013/05/12 → 2013/05/15Activity: Talk or presentation › Oral presentation
-
Pharmacological blockade of spinally-sensitized dorsal horn neurons in a reserpine-induced fibromyalgia mode.
Uta, D. (Speaker)
2020/03/17 → 2020/03/19Activity: Talk or presentation › Oral presentation
-
Pharmacological and histochemical characterization of a mouse model of chronic renal failure-associated pruritus.
Uta, D. (Speaker)
2017/10Activity: Talk or presentation › Oral presentation
-
PeT を利用した光アフィニティー蛍光ラベル法の開発
Chiba, J. (Speaker)
2016/06/15 → 2016/06/17Activity: Talk or presentation › Oral presentation
-
PeT-regulated tagging method for PAL-based identification of interacting protein
Tomohiro, T. (Speaker)
2019/05/19 → 2019/05/22Activity: Talk or presentation › Oral presentation
-
PeT-based photochemical fluorophore labeling for target identification
Chiba, J. (Speaker)
2016/09/12 → 2016/09/13Activity: Talk or presentation › Oral presentation
-
PDGF受容体活性阻害による2型糖尿病マウスのインスリン感受性改善機構.
Sasaoka, T. (Speaker)
2014/05/22 → 2014/05/24Activity: Talk or presentation › Oral presentation
-
PDGF受容体活性阻害による2型糖尿病マウスのインスリン感受性改善機構.
Wada, T. (Speaker)
2014/05/22 → 2014/05/24Activity: Talk or presentation › Oral presentation
-
PDGF受容体活性阻害による2型糖尿病マウスのインスリン感受性改善機構.
Tsuneki, H. (Speaker)
2014/05/22 → 2014/05/24Activity: Talk or presentation › Oral presentation
-
PDGFシグナル遮断がインスリン抵抗性に与える影響.
Sasaoka, T. (Speaker)
2015/05/21 → 2015/05/24Activity: Talk or presentation › Oral presentation
-
PDGFシグナル遮断がインスリン抵抗性に与える影響.
Tsuneki, H. (Speaker)
2015/05/21 → 2015/05/24Activity: Talk or presentation › Oral presentation
-
PDGFシグナル遮断がインスリン抵抗性に与える影響.
Wada, T. (Speaker)
2015/05/21 → 2015/05/24Activity: Talk or presentation › Oral presentation
-
PDGFシグナルが肥満に伴う脂肪組織の肥大化と糖代謝におよぼす影響.
Sasaoka, T. (Speaker)
2015/07/09 → 2015/07/11Activity: Talk or presentation › Oral presentation
-
PDGFシグナルが肥満に伴う脂肪組織の肥大化と糖代謝におよぼす影響.
Tsuneki, H. (Speaker)
2015/07/09 → 2015/07/11Activity: Talk or presentation › Oral presentation
-
PDGFシグナルが肥満に伴う脂肪組織の肥大化と糖代謝におよぼす影響.
Wada, T. (Speaker)
2015/07/09 → 2015/07/11Activity: Talk or presentation › Oral presentation
-
PDGFを介した脂肪組織肥大化およびインスリン抵抗性進展機構の解明.
Wada, T. (Speaker)
2014/11/16Activity: Talk or presentation › Oral presentation
-
PDGFを介した脂肪組織肥大化およびインスリン抵抗性進展機構の解明.
Tsuneki, H. (Speaker)
2014/11/16Activity: Talk or presentation › Oral presentation
-
PDGFを介した脂肪組織肥大化およびインスリン抵抗性進展機構の解明.
Sasaoka, T. (Speaker)
2014/11/16Activity: Talk or presentation › Oral presentation
-
PCLOの一塩基多型が双極性障害に関連する精神・神経機能に対する分子生物学的検討
Nitta, A. (Speaker)
2013/07/20 → 2013/07/21Activity: Talk or presentation › Oral presentation
-
PCLO SNP rs13438494 regulates DA and 5-HT uptake, accompanied with splicing efficiency and dependence-like behaviors in genomic association studies
Nitta, A. (Speaker)
2014/06/22 → 2014/06/26Activity: Talk or presentation › Oral presentation
-
PCLO SNP regulates DA and 5-HT uptake in their transporter over expressed PC12 or HEK293 cells
Nitta, A. (Speaker)
2013/06/19Activity: Talk or presentation › Oral presentation
-
PBLチュートリアル教育プログラムの現状と取り組み
Nitta, A. (Speaker)
2013/03/27 → 2013/03/30Activity: Talk or presentation › Oral presentation
-
PanaxytriolはLPS誘発脳内炎症マウスモデルにおける活性化ミクログリアを抑制する.
Uta, D. (Speaker)
2021/03/26 → 2021/03/29Activity: Talk or presentation › Oral presentation
-
Panaxytriolのミクログリア活性化抑制作用機序の解析.
Uta, D. (Speaker)
2020/09/04Activity: Talk or presentation › Oral presentation
-
PanaxytriolによるLPS誘発ミクログリアの活性化抑制作用.
Uta, D. (Speaker)
2020/11/15Activity: Talk or presentation › Oral presentation
-
Panaxytriol inhibits lipopolysaccharide-induced microglia activation in brain inflammation mouse model
Uta, D. (Speaker)
2021/09/15 → 2021/09/17Activity: Talk or presentation › Oral presentation
-
Panaxytriol inhibits lipopolysaccharide induced microglia activation
Uta, D. (Speaker)
2021/11/08 → 2021/11/11Activity: Talk or presentation › Oral presentation
-
PAL-based fluorogenic tagging for structural analysis of ligand binding state within target protein
Chiba, J. (Speaker)
2017/09/19 → 2017/09/20Activity: Talk or presentation › Oral presentation
-
Paclitaxel 誘発末梢神経障害性疼痛モデルマウスにおける行動薬理学的及び電気生理学的解析.
Uta, D. (Speaker)
2021/02/06Activity: Talk or presentation › Oral presentation
-
Paclitaxel-induced peripheral neuropathic pain formation contributes to synaptic plasticity in the spinal dorsal horn.
Uta, D. (Speaker)
2022/11/30 → 2022/12/03Activity: Talk or presentation › Oral presentation
-
Scientific elucidation of the optimal lifestyle for subjective good health.
Inada, Y. (Speaker)
2021Activity: Talk or presentation › Oral presentation
-
P-47 マクロスフェライド類を基盤とした新規生理活性物質の設計、合成、活性評価(ポスター発表の部)
Matsuya, Y. (Speaker)
2006Activity: Talk or presentation › Oral presentation
-
P-25 抗腫瘍性ステロイドサポニンOSW-1類似化合物の立体選択的合成と活性評価(ポスター発表の部)
Matsuya, Y. (Speaker)
2005Activity: Talk or presentation › Oral presentation
-
P2-332 高度肥満患者ではリネゾリドの血中濃度が上昇しない可能性がある(薬物動態・TDM・投与設計,ポスター,一般演題,岐路に立つ医療~千年紀の目覚め~よみがえれ!ニッポン!薬の改革は我らが手で!)
To, H. (Speaker)
2012Activity: Talk or presentation › Oral presentation
-
o-ヒドロキシ桂皮酸型ジアリジン誘導体の合成と光反応
Chiba, J. (Speaker)
2011/11/27Activity: Talk or presentation › Oral presentation